Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GLUE · NASDAQ · Biological Products, (No Diagnostic Substances)
$8.64−0.27 (−3.03%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Monte Rosa Therapeutics (GLUE) · oqro.io/stocks/GLUE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Chen Yu cut its GLUE stake below 5% (4.4%)SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office no longer reported GLUE for Q3 2026SourceInsider trade · Traded Oct 5, 2026 · Filed Oct 7, 2026
Officer sold ~$137 of GLUE shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Duquesne Family Office disclosed a new position in GLUE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Montanova Capital, LLC disclosed a reduced position in GLUE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed a reduced position in GLUE for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bellevue Group AG disclosed a new position in GLUE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frazier Life Sciences Management, L.P. disclosed a new position in GLUE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Montanova Capital, LLC disclosed an increased position in GLUE for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Baker Bros. Advisors LP disclosed a reduced position in GLUE for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Avoro Capital Advisors LLC no longer reported GLUE for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Montanova Capital, LLC disclosed an increased position in GLUE for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in GLUE for Q2 2025SourceInsider trade · Traded Jun 3, 2025 · Filed Jun 4, 2025
Officer sold ~$9.2K of GLUE shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC disclosed an increased position in GLUE for Q1 2025SourceInsider trade · Traded Mar 24, 2025 · Filed Mar 25, 2025
Director purchased ~$58K of GLUE shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Montanova Capital, LLC disclosed a reduced position in GLUE for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in GLUE for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Avoro Capital Advisors LLC disclosed an increased position in GLUE for Q3 2024SourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
10% owner sold ~$869K of GLUE shares in the open marketSourceInsider trade · Traded Oct 29, 2024 · Filed Oct 30, 2024
10% owner sold ~$475K of GLUE shares in the open marketSourceInsider trade · Traded Oct 29, 2024 · Filed Oct 30, 2024
10% owner sold ~$147K of GLUE shares in the open marketSource